Danish biotech firm Visibuilt has successfully secured €3.34 million in a seed funding round to advance its sustainable construction materials. The investment was co-led by EIFO and Unconventional Ventures, with participation from Proptechfonden and existing investor EMDFonden. This capital injection will enable the company to transition its innovative biobased binder from laboratory pilots to large-scale market validation.
A Sustainable Alternative for Construction
The global construction industry heavily relies on carbon-intensive binders like cement and bitumen, which are significant contributors to CO₂ emissions. Visibuilt addresses this challenge with its flagship product, visiBINDER, a novel binder derived from mycelium. This biobased solution is specifically designed for paving and other infrastructure applications, offering a greener alternative.
By leveraging biotechnology and material science, Visibuilt aims to create a new class of lower-impact construction materials. The visiBINDER technology provides a less energy-intensive production process compared to its conventional counterparts. It is engineered to meet the stringent durability and performance standards required for demanding outdoor environments.
Investor Confidence and Strategic Vision
The funding round reflects strong investor confidence in Visibuilt's potential to decarbonize heavy industries. Sara Sande of EIFO highlighted that new solutions are essential for reducing global emissions from concrete and asphalt production. She noted that Visibuilt's innovative approach could be a crucial component of this necessary green transition.
Thea Messel from Unconventional Ventures praised the company's model, where environmental impact and commercial success are intrinsically linked. She emphasized that every tonne of visiBINDER sold directly displaces fossil-based products and reduces embedded carbon. Messel also commended founder Line Kloster Pedersen's exceptional execution in securing key industry partnerships so early.
Charting the Path to Market
With the new capital, Visibuilt plans to significantly expand its testing and validation activities with industry partners. The funding will also facilitate the establishment of a production setup capable of supporting larger-scale trials. Furthermore, the company intends to strengthen its team by recruiting additional technical and commercial experts.
Founded in 2022, Visibuilt has made remarkable progress in a short period, demonstrating significant market traction. CEO Line Kloster Pedersen stated that this seed round is a critical milestone for maturing the company's technical platform. These efforts will prepare the company for a successful market introduction and future commercialization of its technology.
This €3.34 million seed investment marks a pivotal moment for Visibuilt, providing the necessary resources to scale its groundbreaking technology. The company is now well-positioned to demonstrate the real-world viability of its mycelium-based binder in demanding infrastructure projects. Ultimately, Visibuilt's success could pave the way for a new era of sustainable materials in the construction sector.